STING-Dependent Signaling Underlies IL-10 Controlled Inflammatory Colitis

Area of Science:

• Immunology
• Microbiology
• Gastroenterology

Background:

• Intestinal immune homeostasis relies on commensal bacteria and cytokine balance for repair and infection control.
• Inflammatory bowel disease (IBD) and colitis-associated cancer (CAC) are linked to chronic microbial irritation and breaches in the intestinal epithelium.
• Innate immune pathways regulating intestinal inflammation require further clarification.

Purpose of the Study:

• To investigate the role of STING signaling in regulating intestinal immune responses to commensal bacteria.
• To elucidate the mechanisms by which commensal bacteria influence innate immune pathways in the gut.
• To identify potential therapeutic targets for preventing IBD.

Main Methods:

• Analysis of STING signaling in mononuclear phagocytes in response to commensal bacteria.
• Assessment of enterocolitis severity in mice lacking STING or cGAS.
• Evaluation of cytokine production, including IL-10, in the context of intestinal inflammation.

Main Results:

• Commensal bacteria modulate STING signaling in mononuclear phagocytes, affecting both pro-inflammatory cytokines and anti-inflammatory IL-10.
• Absence of STING completely abrogated enterocolitis linked to IL-10 loss.
• Reduced intestinal inflammation was observed in the absence of cGAS, suggesting indirect STING regulation via cyclic dinucleotides (CDNs).

Conclusions:

• STING signaling in mononuclear phagocytes is a key regulator of intestinal immune homeostasis in response to commensal bacteria.
• STING plays a critical role in preventing severe enterocolitis and maintaining protective IL-10 levels.
• Targeting STING signaling presents a potential therapeutic strategy for the prevention and treatment of IBD.